{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:30:33Z","timestamp":1792783833635,"version":"4.5.0"},"reference-count":194,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012854","name":"Children's Hospital Research Institute of Manitoba","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012854","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009288","name":"Canadian Bureau for International Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009288","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Barth Syndrome Foundation USA\/Canada","id":[{"id":"https:\/\/ror.org\/00p5z3m34","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s11010-020-04021-0","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T17:03:01Z","timestamp":1610038981000},"page":"1605-1629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets"],"prefix":"10.1007","volume":"476","author":[{"given":"Hana M.","family":"Zegallai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1568-6071","authenticated-orcid":false,"given":"Grant M.","family":"Hatch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"4021_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0022-510X(83)90209-5","volume":"62","author":"PG Barth","year":"1983","unstructured":"Barth PG, Scholte HR, Berden JA et al (1983) An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci 62:327\u2013355. https:\/\/doi.org\/10.1016\/0022-510X(83)90209-5","journal-title":"J Neurol Sci"},{"key":"4021_CR2","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S0022-3476(05)80289-6","volume":"119","author":"RI Kelley","year":"1991","unstructured":"Kelley RI, Cheatham JP, Clark BJ et al (1991) X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria. J Pediatr 119:738\u2013747. https:\/\/doi.org\/10.1016\/S0022-3476(05)80289-6","journal-title":"J Pediatr"},{"key":"4021_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/01.DBP.0000257519.79803.90","volume":"28","author":"MMM Mazzocco","year":"2007","unstructured":"Mazzocco MMM, Henry AE, Kelly RI (2007) Barth syndrome is associated with a cognitive phenotype. J Dev Behav Pediatr 28:22\u201330. https:\/\/doi.org\/10.1097\/01.DBP.0000257519.79803.90","journal-title":"J Dev Behav Pediatr"},{"key":"4021_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1750-1172-8-70","volume":"8","author":"C Rigaud","year":"2013","unstructured":"Rigaud C, Lebre A-S, Touraine R et al (2013) Natural history of Barth syndrome: A national cohort study of 22 patients. Orphanet J Rare Dis 8:70\u201370. https:\/\/doi.org\/10.1186\/1750-1172-8-70","journal-title":"Orphanet J Rare Dis"},{"key":"4021_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/ajmg.a.20660","volume":"126A","author":"PG Barth","year":"2004","unstructured":"Barth PG, Valianpour F, Bowen VM et al (2004) X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): An update. Am J Med Genet 126A:349\u2013354","journal-title":"Am J Med Genet"},{"key":"4021_CR6","doi-asserted-by":"publisher","first-page":"39217","DOI":"10.1074\/jbc.M606100200","volume":"281","author":"Y Xu","year":"2006","unstructured":"Xu Y, Malhotra A, Ren M, Schlame M (2006) The enzymatic function of Tafazzin. J Biol Chem 281:39217\u201339224. https:\/\/doi.org\/10.1074\/jbc.M606100200","journal-title":"J Biol Chem"},{"key":"4021_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1373\/clinchem.2007.095711","volume":"54","author":"W Kulik","year":"2008","unstructured":"Kulik W, van Lenthe H, Stet FS et al (2008) Bloodspot assay using HPLC\u2013tandem mass spectrometry for detection of Barth syndrome. Clin Chem 54:371. https:\/\/doi.org\/10.1373\/clinchem.2007.095711","journal-title":"Clin Chem"},{"key":"4021_CR8","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/j.bbamem.2009.03.014","volume":"1788","author":"RNAH Lewis","year":"2009","unstructured":"Lewis RNAH, McElhaney RN (2009) The physicochemical properties of cardiolipin bilayers and cardiolipin \u2013 containing lipid membranes. Biochim Biophys Acta Biomembr 1788:2069\u20132079. https:\/\/doi.org\/10.1016\/j.bbamem.2009.03.014","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"4021_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0021-9258(17)35123-2","volume":"168","author":"MC Pangborn","year":"1947","unstructured":"Pangborn MC (1947) The composition of cardiolipin. J Biol Chem 168:351\u2013361","journal-title":"J Biol Chem"},{"key":"4021_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1083\/jcb.201006159","volume":"192","author":"C Osman","year":"2011","unstructured":"Osman C, Voelker DR, Langer T (2011) Making heads or tails of phospholipids in mitochondria. J Cell Biol 192:7\u201316","journal-title":"J Cell Biol"},{"key":"4021_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/BF02537025","volume":"30","author":"P Cheng","year":"1995","unstructured":"Cheng P, Hatch GM (1995) Inhibition of cardiolipin biosynthesis in the hypoxic rat heart. Lipids 30:513\u2013519. https:\/\/doi.org\/10.1007\/BF02537025","journal-title":"Lipids"},{"key":"4021_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10863-015-9601-4","volume":"48","author":"EM Mejia","year":"2016","unstructured":"Mejia EM, Hatch GM (2016) Mitochondrial phospholipids: Role in mitochondrial function. J Bioenerg Biomembr 48:99\u2013112. https:\/\/doi.org\/10.1007\/s10863-015-9601-4","journal-title":"J Bioenerg Biomembr"},{"key":"4021_CR13","doi-asserted-by":"publisher","first-page":"6264","DOI":"10.1073\/pnas.1015757108","volume":"108","author":"LD Renner","year":"2011","unstructured":"Renner LD, Weibel DB (2011) Cardiolipin microdomains localize to negatively curved regions of Escherichia coli membranes. Proc Natl Acad Sci USA 108:6264\u20136269. https:\/\/doi.org\/10.1073\/pnas.1015757108","journal-title":"Proc Natl Acad Sci USA"},{"key":"4021_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ab.2017.07.009","volume":"552","author":"LD Zorova","year":"2018","unstructured":"Zorova LD, Popkov VA, Plotnikov EY et al (2018) Mitochondrial membrane potential. Anal Biochem 552:50\u201359. https:\/\/doi.org\/10.1016\/j.ab.2017.07.009","journal-title":"Anal Biochem"},{"key":"4021_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.chemphyslip.2005.08.002","volume":"138","author":"M Schlame","year":"2005","unstructured":"Schlame M, Ren M, Xu Y et al (2005) Molecular symmetry in mitochondrial cardiolipins. Chem Phys Lipid 138:38\u201349. https:\/\/doi.org\/10.1016\/j.chemphyslip.2005.08.002","journal-title":"Chem Phys Lipid"},{"key":"4021_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0304-4157(92)90035-9","volume":"1113","author":"FL Hoch","year":"1992","unstructured":"Hoch FL (1992) Cardiolipins and biomembrane function. Biochim Biophys Acta Biomembr 1113:71\u2013133. https:\/\/doi.org\/10.1016\/0304-4157(92)90035-9","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"4021_CR17","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1194\/jlr.M600551-JLR200","volume":"48","author":"GC Sparagna","year":"2007","unstructured":"Sparagna GC, Chicco AJ, Murphy RC, Bristow MR (2007) Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure. J Lipid Res 48:1559\u20131570","journal-title":"J Lipid Res"},{"key":"4021_CR18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1006\/bbrc.2000.3952","volume":"279","author":"P Vreken","year":"2000","unstructured":"Vreken P, Valianpour F, Nijtmans LG et al (2000) Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem Biophys Res Commun 279:378\u2013382. https:\/\/doi.org\/10.1006\/bbrc.2000.3952","journal-title":"Biochem Biophys Res Commun"},{"key":"4021_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/MCO.0b013e32834fdaf7","volume":"15","author":"WC Stanley","year":"2012","unstructured":"Stanley WC, Khairallah RJ, Dabkowski ER (2012) Update on lipids and mitochondrial function: Impact of dietary n-3 polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care 15:122\u2013126. https:\/\/doi.org\/10.1097\/MCO.0b013e32834fdaf7","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"4021_CR20","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1128\/EC.00085-09","volume":"8","author":"MW Bratschi","year":"2009","unstructured":"Bratschi MW, Burrowes DP, Kulaga A et al (2009) Glycerol-3-phosphate acyltransferases gat1p and gat2p are microsomal phosphoproteins with differential contributions to polarized cell growth. Eukaryot Cell 8:1184\u20131196. https:\/\/doi.org\/10.1128\/EC.00085-09","journal-title":"Eukaryot Cell"},{"key":"4021_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cmet.2013.03.018","volume":"17","author":"Y Tamura","year":"2013","unstructured":"Tamura Y, Harada Y, Nishikawa S et al (2013) Tam41 is a CDP-diacylglycerol synthase required for cardiolipin biosynthesis in mitochondria. Cell Metab 17:709\u2013718. https:\/\/doi.org\/10.1016\/j.cmet.2013.03.018","journal-title":"Cell Metab"},{"key":"4021_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1139\/o03-074","volume":"82","author":"GM Hatch","year":"2004","unstructured":"Hatch GM (2004) Cell biology of cardiac mitochondrial phospholipids. Biochem Cell Biol 82:99\u2013112. https:\/\/doi.org\/10.1139\/o03-074","journal-title":"Biochem Cell Biol"},{"key":"4021_CR23","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/0006-291X(71)90032-5","volume":"42","author":"JB Davidson","year":"1971","unstructured":"Davidson JB, Stanacev NZ (1971) Biosynthesis of cardiolipin in mitochondria isolated from guinea pig liver. Biochem Biophys Res Commun 42:1191\u20131199. https:\/\/doi.org\/10.1016\/0006-291X(71)90032-5","journal-title":"Biochem Biophys Res Commun"},{"key":"4021_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10863-014-9591-7","volume":"48","author":"C Ye","year":"2016","unstructured":"Ye C, Shen Z, Greenberg ML (2016) Cardiolipin remodeling: A regulatory hub for modulating cardiolipin metabolism and function. J Bioenerg Biomembr 48:113\u2013123. https:\/\/doi.org\/10.1007\/s10863-014-9591-7","journal-title":"J Bioenerg Biomembr"},{"key":"4021_CR25","doi-asserted-by":"publisher","first-page":"31727","DOI":"10.1074\/jbc.M402930200","volume":"279","author":"J Cao","year":"2004","unstructured":"Cao J, Liu Y, Lockwood J et al (2004) A novel cardiolipin-remodeling pathway revealed by a gene encoding an endoplasmic reticulum-associated Acyl-CoA: Lysocardiolipin Acyltransferase (ALCAT1) in mouse. J Biol Chem 279:31727\u201331734. https:\/\/doi.org\/10.1074\/jbc.M402930200","journal-title":"J Biol Chem"},{"key":"4021_CR26","doi-asserted-by":"publisher","first-page":"12716","DOI":"10.1074\/jbc.M210329200","volume":"278","author":"WA Taylor","year":"2003","unstructured":"Taylor WA, Hatch GM (2003) Purification and characterization of monolysocardiolipin acyltransferase from pig liver mitochondria. J Biol Chem 278:12716\u201312721. https:\/\/doi.org\/10.1074\/jbc.M210329200","journal-title":"J Biol Chem"},{"key":"4021_CR27","doi-asserted-by":"publisher","first-page":"30360","DOI":"10.1074\/jbc.M109.048322","volume":"284","author":"WA Taylor","year":"2009","unstructured":"Taylor WA, Hatch GM (2009) Identification of the human mitochondrial linoleoyl-coenzyme A monolysocardiolipin acyltransferase (MLCLAT-1). J Biol Chem 284:30360\u201330371. https:\/\/doi.org\/10.1074\/jbc.M109.048322","journal-title":"J Biol Chem"},{"key":"4021_CR28","doi-asserted-by":"publisher","first-page":"7564","DOI":"10.1074\/jbc.RA117.001024","volume":"293","author":"EM Mejia","year":"2018","unstructured":"Mejia EM, Zegallai H, Bouchard ED et al (2018) Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts. J Biol Chem 293:7564\u20137577. https:\/\/doi.org\/10.1074\/jbc.RA117.001024","journal-title":"J Biol Chem"},{"key":"4021_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cmet.2010.07.003","volume":"12","author":"J Li","year":"2010","unstructured":"Li J, Romestaing C, Han X et al (2010) Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity. Cell Metab 12:154\u2013165. https:\/\/doi.org\/10.1016\/j.cmet.2010.07.003","journal-title":"Cell Metab"},{"issue":"3","key":"4021_CR30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/bjh.12271","volume":"161","author":"AA Aprikyan","year":"2013","unstructured":"Aprikyan AA, Khuchua Z (2013) Advances in the understanding of Barth syndrome. Br J Haematol 161(3):330\u2013338. https:\/\/doi.org\/10.1111\/bjh.12271","journal-title":"Br J Haematol"},{"key":"4021_CR31","doi-asserted-by":"publisher","first-page":"19434","DOI":"10.1016\/S0021-9258(17)45391-9","volume":"265","author":"KS Eble","year":"1990","unstructured":"Eble KS, Coleman WB, Hantgan RR, Cunningham CC (1990) Tightly associated cardiolipin in the bovine heart mitochondrial ATP synthase as analyzed by 31P nuclear magnetic resonance spectroscopy. J Biol Chem 265:19434\u201319440","journal-title":"J Biol Chem"},{"key":"4021_CR32","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/S0021-9258(19)69888-1","volume":"256","author":"M Fry","year":"1981","unstructured":"Fry M, Green DE (1981) Cardiolipin requirement for electron transfer in complex I and III of the mitochondrial respiratory chain. J Biol Chem 256:1874\u20131880","journal-title":"J Biol Chem"},{"key":"4021_CR33","first-page":"153","volume":"25","author":"NC Robinson","year":"1993","unstructured":"Robinson NC (1993) Functional binding of cardiolipin to cytochrome c oxidase. J BioenergBiomembr 25:153\u2013163","journal-title":"J BioenergBiomembr"},{"key":"4021_CR34","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.freeradbiomed.2011.05.004","volume":"51","author":"K Sugamura","year":"2011","unstructured":"Sugamura K, Keaney John F (2011) Reactive oxygen species in cardiovascular disease. Free Radical Biol Med 51:978\u2013992. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.05.004","journal-title":"Free Radical Biol Med"},{"key":"4021_CR35","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.diabres.2008.09.017","volume":"82","author":"H Ha","year":"2008","unstructured":"Ha H, Hwang I, Park JH, Lee HB (2008) Role of reactive oxygen species in the pathogenesis of diabetic nephropathy. Diabetes Res Clin Pract 82:S42\u2013S45. https:\/\/doi.org\/10.1016\/j.diabres.2008.09.017","journal-title":"Diabetes Res Clin Pract"},{"key":"4021_CR36","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/labinvest.3700274","volume":"85","author":"Y Xu","year":"2005","unstructured":"Xu Y, Sutachan JJ, Plesken H et al (2005) Characterization of lymphoblast mitochondria from patients with Barth syndrome. Lab Invest 85:823\u2013830. https:\/\/doi.org\/10.1038\/labinvest.3700274","journal-title":"Lab Invest"},{"issue":"4","key":"4021_CR37","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.bpj.2014.07.015","volume":"107","author":"N Khalifat","year":"2014","unstructured":"Khalifat N, Rahimi M, Bitbol A et al (2014) Interplay of packing and flip-flop in local bilayer deformation. How phosphatidylglycerol could rescue mitochondrial function in a cardiolipin-deficient yeast mutant. Biophys J 107(4):879\u2013890. https:\/\/doi.org\/10.1016\/j.bpj.2014.07.015","journal-title":"Biophys J"},{"issue":"15","key":"4021_CR38","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1021\/bi00336a001","volume":"24","author":"K Beyer","year":"1985","unstructured":"Beyer K, Klingenberg M (1985) ADP\/ATP carrier protein from beef heart mitochondria has high amounts of tightly bound cardiolipin, as revealed by phosphorus-31 nuclear magnetic resonance. Biochemistry 24(15):3821\u20133826. https:\/\/doi.org\/10.1021\/bi00336a001","journal-title":"Biochemistry"},{"key":"4021_CR39","doi-asserted-by":"publisher","first-page":"22387","DOI":"10.1074\/jbc.M909868199","volume":"275","author":"F Jiang","year":"2000","unstructured":"Jiang F, Ryan MT, Schlame M et al (2000) Absence of cardiolipin in the crd1 null mutant results in decreased mitochondrial membrane potential and reduced mitochondrial function. J Biol Chem 275:22387\u201322394. https:\/\/doi.org\/10.1074\/jbc.M909868199","journal-title":"J Biol Chem"},{"key":"4021_CR40","doi-asserted-by":"publisher","first-page":"10870","DOI":"10.1074\/jbc.RA118.004014","volume":"293","author":"W Basu Ball","year":"2018","unstructured":"Basu Ball W, Baker CD, Neff JK et al (2018) Ethanolamine ameliorates mitochondrial dysfunction in cardiolipin-deficient yeast cells. J Biol Chem 293:10870\u201310883. https:\/\/doi.org\/10.1074\/jbc.RA118.004014","journal-title":"J Biol Chem"},{"key":"4021_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bbalip.2016.08.010","volume":"1862","author":"M Schlame","year":"2017","unstructured":"Schlame M, Greenberg ML (2017) Biosynthesis, remodeling and turnover of mitochondrial cardiolipin. Biochim Biophys Acta Mol Cell Biol Lipids 1862:3\u20137. https:\/\/doi.org\/10.1016\/j.bbalip.2016.08.010","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"4021_CR42","doi-asserted-by":"publisher","first-page":"376","DOI":"10.4161\/auto.27191","volume":"10","author":"CT Chu","year":"2014","unstructured":"Chu CT, Bay\u0131r H, Kagan VE (2014) LC3 binds externalized cardiolipin on injured mitochondria to signal mitophagy in neurons. Autophagy 10:376\u2013378. https:\/\/doi.org\/10.4161\/auto.27191","journal-title":"Autophagy"},{"key":"4021_CR43","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1091\/mbc.e04-09-0807","volume":"16","author":"T Tatsuta","year":"2005","unstructured":"Tatsuta T, Model K, Langer T (2005) Formation of membrane-bound ring complexes by prohibitins in mitochondria. Mol Biol Cell 16:248\u2013259. https:\/\/doi.org\/10.1091\/mbc.e04-09-0807","journal-title":"Mol Biol Cell"},{"key":"4021_CR44","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1083\/jcb.200803129","volume":"183","author":"F Gonzalvez","year":"2008","unstructured":"Gonzalvez F, Schug ZT, Houtkooper RH et al (2008) Cardiolipin provides an essential activating platform for caspase-8 on mitochondria. J Cell Biol 183:681\u2013696. https:\/\/doi.org\/10.1083\/jcb.200803129","journal-title":"J Cell Biol"},{"key":"4021_CR45","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/35036395","volume":"2","author":"M Lutter","year":"2000","unstructured":"Lutter M, Fang M, Luo X et al (2000) Cardiolipin provides specificity for targeting of tBid to mitochondria. Nat Cell Biol 2:754\u2013756. https:\/\/doi.org\/10.1038\/35036395","journal-title":"Nat Cell Biol"},{"key":"4021_CR46","doi-asserted-by":"publisher","first-page":"52873","DOI":"10.1074\/jbc.M308366200","volume":"278","author":"K Pfeiffer","year":"2003","unstructured":"Pfeiffer K, Gohil V, Stuart RA et al (2003) Cardiolipin stabilizes respiratory chain supercomplexes. J Biol Chem 278:52873\u201352880. https:\/\/doi.org\/10.1074\/jbc.M308366200","journal-title":"J Biol Chem"},{"key":"4021_CR47","doi-asserted-by":"publisher","first-page":"43553","DOI":"10.1074\/jbc.C200551200","volume":"277","author":"M Zhang","year":"2002","unstructured":"Zhang M, Mileykovskaya E, Dowhan W (2002) Gluing the respiratory chain together: Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane. J Biol Chem 277:43553\u201343556. https:\/\/doi.org\/10.1074\/jbc.C200551200","journal-title":"J Biol Chem"},{"key":"4021_CR48","doi-asserted-by":"publisher","first-page":"e0128561","DOI":"10.1371\/journal.pone.0128561","volume":"10","author":"Y Huang","year":"2015","unstructured":"Huang Y, Powers C, Madala SK et al (2015) Cardiac metabolic pathways affected in the mouse model of barth syndrome. PLoS ONE 10:e0128561\u2013e0128561. https:\/\/doi.org\/10.1371\/journal.pone.0128561","journal-title":"PLoS ONE"},{"key":"4021_CR49","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1006\/bbrc.1999.1410","volume":"264","author":"Y Shidoji","year":"1999","unstructured":"Shidoji Y, Hayashi K, Komura S et al (1999) Loss of molecular interaction between cytochrome c and cardiolipin due to lipid peroxidation. Biochem Biophys Res Commun 264:343\u2013347. https:\/\/doi.org\/10.1006\/bbrc.1999.1410","journal-title":"Biochem Biophys Res Commun"},{"key":"4021_CR50","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cellsig.2012.01.008","volume":"24","author":"PD Ray","year":"2012","unstructured":"Ray PD, Huang B-W, Tsuji Y (2012) Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24:981\u2013990. https:\/\/doi.org\/10.1016\/j.cellsig.2012.01.008","journal-title":"Cell Signal"},{"issue":"11","key":"4021_CR51","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1002\/ajmg.a.35609","volume":"158A","author":"AE Roberts","year":"2012","unstructured":"Roberts AE, Nixon C, Steward CG et al (2012) The Barth syndrome registry: Distinguishing disease characteristics and growth data from a longitudinal study. Am J Medi Genet Part A 158A(11):2726\u20132732. https:\/\/doi.org\/10.1002\/ajmg.a.35609","journal-title":"Am J Medi Genet Part A"},{"key":"4021_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1750-1172-8-23","volume":"8","author":"SLN Clarke","year":"2013","unstructured":"Clarke SLN, Bowron A, Gonzalez IL et al (2013) Barth syndrome. Orphanet J Rare Dis 8:23\u201323. https:\/\/doi.org\/10.1186\/1750-1172-8-23","journal-title":"Orphanet J Rare Dis"},{"key":"4021_CR53","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1651-2227.2004.tb02974.x","volume":"93","author":"MR Schmidt","year":"2004","unstructured":"Schmidt MR, Birkebaek N, Gonzalez I, Sunde L (2004) Barth syndrome without 3-methylglutaconic aciduria. Acta Paediatr 93:419\u2013421. https:\/\/doi.org\/10.1111\/j.1651-2227.2004.tb02974.x","journal-title":"Acta Paediatr"},{"key":"4021_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10545-010-9210-7","volume":"35","author":"SB Wortmann","year":"2012","unstructured":"Wortmann SB, Kluijtmans LA, Engelke UFH et al (2012) The 3-methylglutaconic acidurias: What\u2019s new? J Inherit Metab Dis 35:13\u201322. https:\/\/doi.org\/10.1007\/s10545-010-9210-7","journal-title":"J Inherit Metab Dis"},{"key":"4021_CR55","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1203\/00006450-199505000-00020","volume":"37","author":"RI Kelley","year":"1995","unstructured":"Kelley RI, Kratz L (1995) 3-methylglutaconic acidemia in Smith-Lemli-Opitz syndrome. Pediatr Res 37:671\u2013674. https:\/\/doi.org\/10.1203\/00006450-199505000-00020","journal-title":"Pediatr Res"},{"key":"4021_CR56","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jpeds.2016.12.070","volume":"183","author":"L Woiewodski","year":"2017","unstructured":"Woiewodski L, Ezon D, Cooper J, Feingold B (2017) Barth syndrome with late-onset cardiomyopathy: A missed opportunity for diagnosis. J Pediatr 183:196\u2013198. https:\/\/doi.org\/10.1016\/j.jpeds.2016.12.070","journal-title":"J Pediatr"},{"key":"4021_CR57","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/gim.2015.204","volume":"18","author":"WR Thompson","year":"2016","unstructured":"Thompson WR, DeCroes B, McClellan R et al (2016) New targets for monitoring and therapy in Barth syndrome. Genet Med 18:1001\u20131010. https:\/\/doi.org\/10.1038\/gim.2015.204","journal-title":"Genet Med"},{"key":"4021_CR58","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2147\/JMDH.S54802","volume":"8","author":"S Reynolds","year":"2015","unstructured":"Reynolds S (2015) Successful management of Barth syndrome: A systematic review highlighting the importance of a flexible and multidisciplinary approach. J Multidiscip Healthc 8:345\u2013358. https:\/\/doi.org\/10.2147\/JMDH.S54802","journal-title":"J Multidiscip Healthc"},{"key":"4021_CR59","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.bbadis.2018.08.025","volume":"1865","author":"J Dudek","year":"2019","unstructured":"Dudek J, Hartmann M, Rehling P (2019) The role of mitochondrial cardiolipin in heart function and its implication in cardiac disease. Biochim Biophys Acta Mol Basis Dis 1865:810\u2013821. https:\/\/doi.org\/10.1016\/j.bbadis.2018.08.025","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4021_CR60","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/cvr\/cvx014","volume":"113","author":"J Dudek","year":"2017","unstructured":"Dudek J, Maack C (2017) Barth syndrome cardiomyopathy. Cardiovasc Res 113:399\u2013410. https:\/\/doi.org\/10.1093\/cvr\/cvx014","journal-title":"Cardiovasc Res"},{"key":"4021_CR61","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fcvm.2016.00025","volume":"3","author":"AW El-Hattab","year":"2016","unstructured":"El-Hattab AW, Scaglia F (2016) Mitochondrial cardiomyopathies. Front Cardiovasc Med 3:25\u201325. https:\/\/doi.org\/10.3389\/fcvm.2016.00025","journal-title":"Front Cardiovasc Med"},{"key":"4021_CR62","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/cvr\/cvm005","volume":"77","author":"\u00c5B Gustafsson","year":"2008","unstructured":"Gustafsson \u00c5B, Gottlieb RA (2008) Heart mitochondria: Gates of life and death. Cardiovasc Res 77:334\u2013343. https:\/\/doi.org\/10.1093\/cvr\/cvm005","journal-title":"Cardiovasc Res"},{"issue":"1","key":"4021_CR63","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/moh.0b013e32835a01d9","volume":"20","author":"J Finsterer","year":"2013","unstructured":"Finsterer J, Frank M (2013) Haematological features in Barth syndrome. Curr Opin Hematol 20(1):36\u201340. https:\/\/doi.org\/10.1097\/moh.0b013e32835a01d9","journal-title":"Curr Opin Hematol"},{"issue":"10","key":"4021_CR64","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1182\/blood-2003-11-3940","volume":"103","author":"TW Kuijpers","year":"2004","unstructured":"Kuijpers TW (2004) Neutrophils in Barth syndrome (BTHS) avidly bind annexin-V in the absence of apoptosis. Blood 103(10):3915\u20133923. https:\/\/doi.org\/10.1182\/blood-2003-11-3940","journal-title":"Blood"},{"key":"4021_CR65","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1600-0609.2011.01725.x","volume":"88","author":"V Makaryan","year":"2012","unstructured":"Makaryan V, Kulik W, Vaz FM et al (2012) The cellular and molecular mechanisms for neutropenia in Barth syndrome. Eur J Haematol 88:195\u2013209. https:\/\/doi.org\/10.1111\/j.1600-0609.2011.01725.x","journal-title":"Eur J Haematol"},{"key":"4021_CR66","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1023\/A:1012711009687","volume":"24","author":"SR Bergmann","year":"2001","unstructured":"Bergmann SR, Herrero P, Sciacca R et al (2001) Characterization of altered myocardial fatty acid metabolism in patients with inherited cardiomyopathy. J Inherit Metab Dis 24:657\u2013674","journal-title":"J Inherit Metab Dis"},{"key":"4021_CR67","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0735-1097(02)01967-8","volume":"40","author":"VG D\u00e1vila-Rom\u00e1n","year":"2002","unstructured":"D\u00e1vila-Rom\u00e1n VG, Vedala G, Herrero P et al (2002) Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 40:271\u2013277. https:\/\/doi.org\/10.1016\/S0735-1097(02)01967-8","journal-title":"J Am Coll Cardiol"},{"key":"4021_CR68","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10545-012-9486-x","volume":"36","author":"WT Cade","year":"2013","unstructured":"Cade WT, Spencer CT, Reeds DN et al (2013) Substrate metabolism during basal and hyperinsulinemic conditions in adolescents and young-adults with Barth syndrome. J Inherit Metab Dis 36:91\u2013101. https:\/\/doi.org\/10.1007\/s10545-012-9486-x","journal-title":"J Inherit Metab Dis"},{"key":"4021_CR69","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-","volume":"260","author":"H Norrelund","year":"2006","unstructured":"Norrelund H, Wiggers H, Halbirk M et al (2006) Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure. J Intern Med 260:11\u201321. https:\/\/doi.org\/10.1111\/j.1365-","journal-title":"J Intern Med"},{"key":"4021_CR70","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11745-017-4232-7","volume":"52","author":"EM Mejia","year":"2017","unstructured":"Mejia EM, Zinko JC, Hauff KD et al (2017) Glucose uptake and triacylglycerol synthesis are increased in Barth syndrome lymphoblasts. Lipids 52:161\u2013165. https:\/\/doi.org\/10.1007\/s11745-017-4232-7","journal-title":"Lipids"},{"issue":"9","key":"4021_CR71","doi-asserted-by":"publisher","first-page":"H1332","DOI":"10.1152\/ajpheart.00084.2013","volume":"305","author":"Q He","year":"2005","unstructured":"He Q et al (2005) Tafazzin knockdown interrupts cell cycle progression in cultured neonatal ventricular fibroblasts. Am J Physiol Heart CircPhysiol 305(9):H1332\u2013H1343","journal-title":"Am J Physiol Heart CircPhysiol"},{"key":"4021_CR72","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1194\/jlr.M034728","volume":"54","author":"MA Kiebish","year":"2013","unstructured":"Kiebish MA, Yang K, Liu X et al (2013) Dysfunctional cardiac mitochondrial bioenergetic, lipidomic, and signaling in a murine model of Barth syndrome. J Lipid Res 54:1312\u20131325. https:\/\/doi.org\/10.1194\/jlr.M034728","journal-title":"J Lipid Res"},{"key":"4021_CR73","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/DBP.0b013e31824c4090","volume":"33","author":"D Raches","year":"2012","unstructured":"Raches D, Mazzocco MM (2012) Emergence and nature of mathematical difficulties in young children with Barth syndrome. J Dev Behav Pediatr 33:328\u2013335","journal-title":"J Dev Behav Pediatr"},{"key":"4021_CR74","unstructured":"Ferreira, C. et al. (2014). In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132016."},{"key":"4021_CR75","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/02739610902813344","volume":"38","author":"EA Storch","year":"2009","unstructured":"Storch EA, Keeley M, Merlo LJ et al (2009) Psychosocial functioning in youth with Barth syndrome. Child Health Care 38:137\u2013156. https:\/\/doi.org\/10.1080\/02739610902813344","journal-title":"Child Health Care"},{"key":"4021_CR76","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/02739615.2015.1124768","volume":"46","author":"ML Jacob","year":"2017","unstructured":"Jacob ML et al (2017) Psychosocial functioning in Barth syndrome: Assessment of individual and parental adjustment. Child Health Care 46:66\u201392","journal-title":"Child Health Care"},{"key":"4021_CR77","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1021\/bi7023282","volume":"47","author":"H Cheng","year":"2008","unstructured":"Cheng H, Mancuso DJ, Jiang X et al (2008) Shotgun lipidomics reveals the temporally dependent, highly diversified cardiolipin profile in the mammalian brain: Temporally coordinated postnatal diversification of cardiolipin molecular species with neuronal remodeling. Biochemistry 47:5869\u20135880. https:\/\/doi.org\/10.1021\/bi7023282","journal-title":"Biochemistry"},{"key":"4021_CR78","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/j.bbamem.2009.07.009","volume":"1788","author":"RH Houtkooper","year":"2009","unstructured":"Houtkooper RH, Turkenburg M, Poll-The BT et al (2009) The enigmatic role of tafazzin in cardiolipin metabolism. Biochim Biophys Acta Biomembr 1788:2003\u20132014. https:\/\/doi.org\/10.1016\/j.bbamem.2009.07.009","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"4021_CR79","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1016\/j.bbadis.2018.07.022","volume":"1864","author":"LK Cole","year":"2018","unstructured":"Cole LK, Kim JH, Amoscato AA et al (2018) Aberrant cardiolipin metabolism is associated with cognitive deficiency and hippocampal alteration in tafazzin knockdown mice. Biochim Biophys Acta Mol Basis Dis 1864:3353\u20133367. https:\/\/doi.org\/10.1016\/j.bbadis.2018.07.022","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4021_CR80","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1542\/peds.2005-2667","volume":"118","author":"CT Spencer","year":"2006","unstructured":"Spencer CT, Bryant RM, Day J et al (2006) Cardiac and clinical phenotype in Barth syndrome. Pediatrics 118:e337. https:\/\/doi.org\/10.1542\/peds.2005-2667","journal-title":"Pediatrics"},{"key":"4021_CR81","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1139\/O09-186","volume":"88","author":"KD Hauff","year":"2010","unstructured":"Hauff KD, Hatch GM (2010) Reduction in cholesterol synthesis in response to serum starvation in lymphoblasts of a patient with Barth syndrome. This paper is one of a selection of papers published in this special issue entitled \u201cSecond International Symposium on Recent Advances in Basic, Clinical, and Social Medicine\u201d and has undergone the Journal\u2019s usual peer review process. Biochem Cell Biol 88:595\u2013602. https:\/\/doi.org\/10.1139\/O09-186","journal-title":"Biochem Cell Biol"},{"key":"4021_CR82","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.2337\/db16-0114","volume":"65","author":"LK Cole","year":"2016","unstructured":"Cole LK, Mejia EM, Vandel M et al (2016) Impaired cardiolipin biosynthesis prevents hepatic steatosis and diet-induced obesity. Diabetes 65:3289\u20133300. https:\/\/doi.org\/10.2337\/db16-0114","journal-title":"Diabetes"},{"key":"4021_CR83","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1139\/Y09-055","volume":"87","author":"KD Hauff","year":"2009","unstructured":"Hauff KD, Choi S-Y, Frohman MA, Hatch GM (2009) Cardiolipin synthesis is required to support human cholesterol biosynthesis from palmitate upon serum removal in Hela cells. Can J Physiol Pharmacol 87:813\u2013820. https:\/\/doi.org\/10.1139\/Y09-055","journal-title":"Can J Physiol Pharmacol"},{"key":"4021_CR84","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.bcmd.2008.11.004","volume":"42","author":"T Bachou","year":"2009","unstructured":"Bachou T, Giannakopoulos A, Trapali C et al (2009) A novel mutation in the G4.5 (TAZ) gene in a Greek patient with Barth syndrome. Blood Cells Mol Dis 42:262\u2013264. https:\/\/doi.org\/10.1016\/j.bcmd.2008.11.004","journal-title":"Blood Cells Mol Dis"},{"key":"4021_CR85","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1007\/s12098-010-0222-y","volume":"77","author":"E Aljishi","year":"2010","unstructured":"Aljishi E, Ali F (2010) Barth syndrome: An X-linked cardiomyopathy with a novel mutation. Indian J Pediatr 77:1432\u20131433. https:\/\/doi.org\/10.1007\/s12098-010-0222-y","journal-title":"Indian J Pediatr"},{"key":"4021_CR86","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/TACG.S171481","volume":"12","author":"J Finsterer","year":"2019","unstructured":"Finsterer J (2019) Barth syndrome: Mechanisms and management. Appl Clin Genet 12:95\u2013106. https:\/\/doi.org\/10.2147\/TACG.S171481","journal-title":"Appl Clin Genet"},{"key":"4021_CR87","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1399-3046.2006.00629.x","volume":"11","author":"J Mangat","year":"2007","unstructured":"Mangat J, Lunnon-Wood T, Rees P et al (2007) Successful cardiac transplantation in Barth syndrome \u2013 single-centre experience of four patients. Pediatr Transplant 11:327\u2013331. https:\/\/doi.org\/10.1111\/j.1399-3046.2006.00629.x","journal-title":"Pediatr Transplant"},{"issue":"17","key":"4021_CR88","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1161\/circulationaha.118.035455","volume":"138","author":"M Lei","year":"2018","unstructured":"Lei M, Wu L, Terrar DA, Huang CL (2018) Modernized classification of cardiac antiarrhythmic drugs. Circulation 138(17):1879\u20131896. https:\/\/doi.org\/10.1161\/circulationaha.118.035455","journal-title":"Circulation"},{"key":"4021_CR89","unstructured":"Barth Syndrome Foundation. Medications used in Barth syndrome. 2018. Available from: https:\/\/www.barthsyndrome.org\/file_download\/inline\/9339f952-f5cf-4f51-958a-4c89941b2b04. Accessed 10 Feb 2019."},{"key":"4021_CR90","unstructured":"Ferreira C, Thompson R, Vernon H. Barth Syndrome. 2014 Oct 9. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132020. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK247162\/"},{"key":"4021_CR91","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.healun.2008.11.912","volume":"28","author":"J Cassidy","year":"2009","unstructured":"Cassidy J, Haynes S, Kirk R et al (2009) Changing patterns of bridging to heart transplantation in children. J Heart Lung Transplant 28:249\u2013254. https:\/\/doi.org\/10.1016\/j.healun.2008.11.912","journal-title":"J Heart Lung Transplant"},{"key":"4021_CR92","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ejcts.2010.05.015","volume":"39","author":"A Karimova","year":"2011","unstructured":"Karimova A, Van Doorn C, Brown K et al (2011) Mechanical bridging to orthotopic heart transplantation in children weighing less than 10 kg: Feasibility and limitations. Eur J Cardiothorac Surg 39:304\u2013309. https:\/\/doi.org\/10.1016\/j.ejcts.2010.05.015","journal-title":"Eur J Cardiothorac Surg"},{"key":"4021_CR93","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.healun.2003.09.025","volume":"23","author":"WL Holman","year":"2004","unstructured":"Holman WL, Park SJ, Long JW et al (2004) Infection in permanent circulatory support: Experience from the REMATCH trial. J Heart Lung Transplant 23:1359\u20131365. https:\/\/doi.org\/10.1016\/j.healun.2003.09.025","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"4021_CR94","doi-asserted-by":"publisher","first-page":"E46","DOI":"10.1111\/petr.12027","volume":"17","author":"N Dedieu","year":"2012","unstructured":"Dedieu N, Giardini A, Steward CG et al (2012) Successful mechanical circulatory support for 251 days in a child with intermittent severe neutropenia due to Barth syndrome. Pediatr Transplant 17(2):E46\u2013E49. https:\/\/doi.org\/10.1111\/petr.12027","journal-title":"Pediatr Transplant"},{"key":"4021_CR95","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/MOH.0000000000000472","volume":"26","author":"CG Steward","year":"2019","unstructured":"Steward CG, Groves SJ, Taylor CT et al (2019) Neutropenia in Barth syndrome: Characteristics, risks, and management. Curr Opin Hematol 26:6\u201315. https:\/\/doi.org\/10.1097\/MOH.0000000000000472","journal-title":"Curr Opin Hematol"},{"key":"4021_CR96","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/ajmg.c.31372","volume":"163C","author":"JL Jefferies","year":"2013","unstructured":"Jefferies JL (2013) Barth syndrome. Am J Med Genet C Semin Med Genet 163C:198\u2013205. https:\/\/doi.org\/10.1002\/ajmg.c.31372","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"4021_CR97","unstructured":"Kelley R (2008) Management of diarrheal illness in patients with Barth syndrome. https:\/\/www.barthsyndrome.org.uk\/userfiles\/Factsheets\/ManagementofDiarrheainBTHSFactSheet.pdf. Accessed 10 May 2020"},{"key":"4021_CR98","unstructured":"Barth syndrome foundation. Management of diarrheal illness in patients with Barth syndrome. 2008. Available from: https:\/\/www.barthsyndrome.org\/file_download\/inline\/d60a606e-fc62-40b0-bdf0-736edfa5d11a. Accessed 2 March 2019"},{"key":"4021_CR99","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1136\/hrt.72.4.349","volume":"72","author":"I Ostman-Smith","year":"1994","unstructured":"Ostman-Smith I, Brown G, Johnson A, Land JM (1994) Dilated cardiomyopathy due to type II X-linked 3-methylglutaconic aciduria: Successful treatment with pantothenic acid. Br Heart J 72:349\u2013353. https:\/\/doi.org\/10.1136\/hrt.72.4.349","journal-title":"Br Heart J"},{"key":"4021_CR100","first-page":"1","volume":"3","author":"S Reynolds","year":"2015","unstructured":"Reynolds S, Kreider CM, Meeley LE, Bendixen RM (2015) Taste perception and sensory sensitivity: Relationship to feeding problems in boys with Barth Syndrome. J Rare Disord 3:1\u20139","journal-title":"J Rare Disord"},{"issue":"1","key":"4021_CR101","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00455-004-0025-2","volume":"20","author":"SJ Mason","year":"2005","unstructured":"Mason SJ, Harris G, Blissett J (2005) Tube feeding in infancy: Implications for the development of normal eating and drinking skills. Dysphagia 20(1):46\u201361. https:\/\/doi.org\/10.1007\/s00455-004-0025-2","journal-title":"Dysphagia"},{"issue":"1","key":"4021_CR102","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.rec.2012.05.012","volume":"66","author":"M Sabater-Molina","year":"2013","unstructured":"Sabater-Molina M, Guill\u00e9n-Navarro E, Garc\u00eda-Molina E et al (2013) Barth syndrome in adulthood: A clinical case. Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition) 66(1):68\u201370. https:\/\/doi.org\/10.1016\/j.rec.2012.05.012","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"issue":"5","key":"4021_CR103","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/ajmg.a.32822","volume":"149A","author":"HR Singh","year":"2009","unstructured":"Singh HR, Yang Z, Siddiqui S et al (2009) A novel Alu-mediated Xq28 microdeletion ablates TAZ and partially deletes DNL1L in a patient with Barth syndrome. Am J Med Genet Part A 149A(5):1082\u20131085. https:\/\/doi.org\/10.1002\/ajmg.a.32822","journal-title":"Am J Med Genet Part A"},{"key":"4021_CR104","doi-asserted-by":"publisher","first-page":"13130","DOI":"10.14814\/phy2.13130","volume":"5","author":"A Bashir","year":"2017","unstructured":"Bashir A, Bohnert KL, Reeds DN et al (2017) Impaired cardiac and skeletal muscle bioenergetics in children, adolescents, and young adults with Barth syndrome. Physiol Rep 5:13130. https:\/\/doi.org\/10.14814\/phy2.13130","journal-title":"Physiol Rep"},{"issue":"12","key":"4021_CR105","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1093\/brain\/awl149","volume":"129","author":"TD Jeppesen","year":"2006","unstructured":"Jeppesen TD, Schwartz M, Olsen DB et al (2006) Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy. Brain 129(12):3402\u20133412. https:\/\/doi.org\/10.1093\/brain\/awl149","journal-title":"Brain"},{"key":"4021_CR106","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1074\/jbc.M110.171439","volume":"286","author":"D Acehan","year":"2011","unstructured":"Acehan D, Vaz F, Houtkooper RH et al (2011) Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome. J Biol Chem 286:899\u2013908. https:\/\/doi.org\/10.1074\/jbc.M110.171439","journal-title":"J Biol Chem"},{"key":"4021_CR107","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s10545-015-9834-8","volume":"38","author":"MS Soustek","year":"2015","unstructured":"Soustek MS, Baligand C, Falk DJ et al (2015) Endurance training ameliorates complex 3 deficiency in a mouse model of Barth syndrome. J Inherit Metab Dis 38:915\u2013922. https:\/\/doi.org\/10.1007\/s10545-015-9834-8","journal-title":"J Inherit Metab Dis"},{"key":"4021_CR108","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1089\/ars.2011.4498","volume":"18","author":"Z Radak","year":"2013","unstructured":"Radak Z, Zhao Z, Koltai E et al (2013) Oxygen consumption and usage during physical exercise: The balance between oxidative stress and ROS-dependent adaptive signaling. Antioxid Redox Signal 18:1208\u20131246. https:\/\/doi.org\/10.1089\/ars.2011.4498","journal-title":"Antioxid Redox Signal"},{"key":"4021_CR109","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/8904_2016_553","volume":"32","author":"WT Cade","year":"2017","unstructured":"Cade WT, Reeds DN, Peterson LR et al (2017) Endurance exercise training in young adults with Barth syndrome: A pilot study. JIMD Rep 32:15\u201324. https:\/\/doi.org\/10.1007\/8904_2016_553","journal-title":"JIMD Rep"},{"issue":"2","key":"4021_CR110","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/ana.1050","volume":"50","author":"T Taivassalo","year":"2001","unstructured":"Taivassalo T, Shoubridge EA, Chen J et al (2001) Aerobic conditioning in patients with mitochondrial myopathies: Physiological, biochemical, and genetic effects. Ann Neurol 50(2):133\u2013141. https:\/\/doi.org\/10.1002\/ana.1050","journal-title":"Ann Neurol"},{"key":"4021_CR111","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/8904_2018_102","volume":"41","author":"AJ Bittel","year":"2018","unstructured":"Bittel AJ, Bohnert KL, Reeds DN et al (2018) Reduced muscle strength in Barth syndrome may be improved by resistance exercise training: A pilot study. JIMD Rep 41:63\u201372. https:\/\/doi.org\/10.1007\/8904_2018_102","journal-title":"JIMD Rep"},{"key":"4021_CR112","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1161\/01.CIR.99.9.1173","volume":"99","author":"B Romualdo","year":"1999","unstructured":"Romualdo B, Demetrios G, Giovanni C, Augusto P (1999) Randomized, controlled trial of long-term moderate exercise training in chronic heart failure. Circulation 99:1173\u20131182. https:\/\/doi.org\/10.1161\/01.CIR.99.9.1173","journal-title":"Circulation"},{"key":"4021_CR113","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/2040622313480382","volume":"4","author":"C De Maeyer","year":"2013","unstructured":"De Maeyer C, Beckers P, Vrints CJ, Conraads VM (2013) Exercise training in chronic heart failure. Ther Adv Chronic Dis 4:105\u2013117. https:\/\/doi.org\/10.1177\/2040622313480382","journal-title":"Ther Adv Chronic Dis"},{"key":"4021_CR114","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.3390\/nu11112636","volume":"11","author":"LA Consitt","year":"2019","unstructured":"Consitt LA, Dudley C, Saxena G (2019) Impact of endurance and resistance training on skeletal muscle glucose metabolism in older adults. Nutrients 11:2636. https:\/\/doi.org\/10.3390\/nu11112636","journal-title":"Nutrients"},{"key":"4021_CR115","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1007\/s00246-012-0258-z","volume":"33","author":"SP Hanke","year":"2012","unstructured":"Hanke SP, Gardner AB, Lombardi JP et al (2012) Left ventricular noncompaction cardiomyopathy in Barth syndrome: An example of an undulating cardiac phenotype necessitating mechanical circulatory support as a bridge to transplantation. Pediatr Cardiol 33:1430\u20131434. https:\/\/doi.org\/10.1007\/s00246-012-0258-z","journal-title":"Pediatr Cardiol"},{"key":"4021_CR116","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.bbamem.2013.11.010","volume":"1838","author":"GL Nicolson","year":"2014","unstructured":"Nicolson GL, Ash ME (2014) Lipid replacement therapy: A natural medicine approach to replacing damaged lipids in cellular membranes and organelles and restoring function. Biochim Biophys Acta Biomembr 1838:1657\u20131679. https:\/\/doi.org\/10.1016\/j.bbamem.2013.11.010","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"4021_CR117","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1194\/jlr.M200217-JLR200","volume":"44","author":"FF Valianpour","year":"2002","unstructured":"Valianpour FF, Wanders R, Overmars H (2002) Linoleic acid supplementation of Barth syndrome fibroblasts restores cardiolipin levels: Implications for treatment. J Lipid Res 44:560\u2013566","journal-title":"J Lipid Res"},{"key":"4021_CR118","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.bbrc.2015.07.012","volume":"464","author":"N Ikon","year":"2015","unstructured":"Ikon N, Su B, Hsu F-F et al (2015) Exogenous cardiolipin localizes to mitochondria and prevents TAZ knockdown-induced apoptosis in myeloid progenitor cells. Biochem Biophys Res Commun 464:580\u2013585. https:\/\/doi.org\/10.1016\/j.bbrc.2015.07.012","journal-title":"Biochem Biophys Res Commun"},{"key":"4021_CR119","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1089\/hum.2010.199","volume":"22","author":"MS Soustek","year":"2011","unstructured":"Soustek MS, Falk DJ, Mah CS et al (2011) Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency. Hum Gene Ther 22:865\u2013871. https:\/\/doi.org\/10.1089\/hum.2010.199","journal-title":"Hum Gene Ther"},{"key":"4021_CR120","doi-asserted-by":"publisher","first-page":"jah3-e00455","DOI":"10.1161\/JAHA.111.000455","volume":"1","author":"CKL Phoon","year":"2012","unstructured":"Phoon CKL, Acehan D, Schlame M et al (2012) Tafazzin knockdown in mice leads to a developmental cardiomyopathy with early diastolic dysfunction preceding myocardial noncompaction. J Am Heart Assoc 1:jah3-e00455. https:\/\/doi.org\/10.1161\/JAHA.111.000455","journal-title":"J Am Heart Assoc"},{"key":"4021_CR121","doi-asserted-by":"publisher","first-page":"107","DOI":"10.7555\/JBR.32.20170094","volume":"32","author":"N Ikon","year":"2018","unstructured":"Ikon N, Hsu F-F, Shearer J et al (2018) Evaluation of cardiolipin nanodisks as lipid replacement therapy for Barth syndrome. J Biomed Res 32:107\u2013112. https:\/\/doi.org\/10.7555\/JBR.32.20170094","journal-title":"J Biomed Res"},{"key":"4021_CR122","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1042\/BJ4370575u","volume":"437","author":"MD Brand","year":"2011","unstructured":"Brand MD, Nicholls DG (2011) Assessing mitochondrial dysfunction in cells. Biochem J 437:575\u2013575","journal-title":"Biochem J"},{"key":"4021_CR123","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jmb.2006.06.057","volume":"361","author":"M McKenzie","year":"2006","unstructured":"McKenzie M, Lazarou M, Thorburn DR, Ryan MT (2006) Mitochondrial respiratory chain supercomplexes are destabilized in Barth syndrome patients. J Mol Biol 361:462\u2013469. https:\/\/doi.org\/10.1016\/j.jmb.2006.06.057","journal-title":"J Mol Biol"},{"key":"4021_CR124","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0378-1119(01)00814-9","volume":"286","author":"G Paradies","year":"2002","unstructured":"Paradies G, Petrosillo G, Pistolese M, Ruggiero FM (2002) Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage. Gene 286:135\u2013141. https:\/\/doi.org\/10.1016\/S0378-1119(01)00814-9","journal-title":"Gene"},{"key":"4021_CR125","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1475-2891-13-17","volume":"13","author":"B Grygiel-G\u00f3rniak","year":"2014","unstructured":"Grygiel-G\u00f3rniak B (2014) Peroxisome proliferator-activated receptors and their ligands: Nutritional and clinical implications\u2013a review. Nutr J 13:17\u201317. https:\/\/doi.org\/10.1186\/1475-2891-13-17","journal-title":"Nutr J"},{"key":"4021_CR126","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4103\/2231-4040.90879","volume":"2","author":"S Tyagi","year":"2011","unstructured":"Tyagi S, Gupta P, Saini AS et al (2011) The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases. J Adv Pharm Technol Res 2:236\u2013240. https:\/\/doi.org\/10.4103\/2231-4040.90879","journal-title":"J Adv Pharm Technol Res"},{"key":"4021_CR127","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1001\/archinte.165.10.1154","volume":"165","author":"A Tenenbaum","year":"2005","unstructured":"Tenenbaum A, Motro M, Fisman EZ et al (2005) Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome. Arch Intern Med 165:1154\u20131160. https:\/\/doi.org\/10.1001\/archinte.165.10.1154","journal-title":"Arch Intern Med"},{"issue":"1","key":"4021_CR128","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/clpt.2010.55","volume":"88","author":"JP Bonnefont","year":"2010","unstructured":"Bonnefont JP, Bastin J, Lafor\u00eat P et al (2010) Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency. Clin Pharmacol Ther 88(1):101\u2013108. https:\/\/doi.org\/10.1038\/clpt.2010.55","journal-title":"Clin Pharmacol Ther"},{"key":"4021_CR129","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13023-017-0605-5","volume":"12","author":"Y Huang","year":"2017","unstructured":"Huang Y, Powers C, Moore V et al (2017) The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome. Orphanet J Rare Dis 12:49\u201349. https:\/\/doi.org\/10.1186\/s13023-017-0605-5","journal-title":"Orphanet J Rare Dis"},{"key":"4021_CR130","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fphar.2018.00318","volume":"9","author":"C Schafer","year":"2018","unstructured":"Schafer C, Moore V, Dasgupta N et al (2018) The effects of PPAR stimulation on cardiac metabolic pathways in Barth syndrome mice. Front Pharmacol 9:318\u2013318. https:\/\/doi.org\/10.3389\/fphar.2018.00318","journal-title":"Front Pharmacol"},{"key":"4021_CR131","doi-asserted-by":"publisher","first-page":"51380","DOI":"10.1074\/jbc.M307382200","volume":"278","author":"Y Xu","year":"2003","unstructured":"Xu Y, Kelley RI, Blanck TJJ, Schlame M (2003) Remodeling of cardiolipin by phospholipid transacylation. J Biol Chem 278:51380\u201351385. https:\/\/doi.org\/10.1074\/jbc.M307382200","journal-title":"J Biol Chem"},{"issue":"2","key":"4021_CR132","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/hum.2018.020","volume":"30","author":"S Suzuki-Hatano","year":"2019","unstructured":"Suzuki-Hatano S, Saha M, Rizzo SA, Witko RL et al (2019) AAV-mediated TAZ gene replacement restores mitochondrial and cardioskeletal function in Barth syndrome. Hum Gene Ther 30(2):139\u2013154. https:\/\/doi.org\/10.1089\/hum.2018.020","journal-title":"Hum Gene Ther"},{"key":"4021_CR133","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1128\/jvi.77.6.3495-3504.2003","volume":"77","author":"BC Schnepp","year":"2003","unstructured":"Schnepp BC, Clark KR, Klemanski DL et al (2003) Genetic fate of recombinant adeno-associated virus vector genomes in muscle. J Virol 77:3495\u20133504. https:\/\/doi.org\/10.1128\/jvi.77.6.3495-3504.2003","journal-title":"J Virol"},{"key":"4021_CR134","doi-asserted-by":"publisher","first-page":"12991","DOI":"10.1073\/pnas.0805802105","volume":"105","author":"R-J Swijnenburg","year":"2008","unstructured":"Swijnenburg R-J, Schrepfer S, Govaert JA et al (2008) Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc Natl Acad Sci USA 105:12991\u201312996. https:\/\/doi.org\/10.1073\/pnas.0805802105","journal-title":"Proc Natl Acad Sci USA"},{"key":"4021_CR135","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2050-490X-2-4","volume":"2","author":"P Liang","year":"2014","unstructured":"Liang P, Du J (2014) Human induced pluripotent stem cell for modeling cardiovascular diseases. Regen Med Res 2:4\u20134. https:\/\/doi.org\/10.1186\/2050-490X-2-4","journal-title":"Regen Med Res"},{"key":"4021_CR136","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ahj.2011.07.020","volume":"162","author":"TJ Povsic","year":"2011","unstructured":"Povsic TJ, O\u2019Connor CM, Henry T et al (2011) A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction. Am Heart J 162:654-662.e1. https:\/\/doi.org\/10.1016\/j.ahj.2011.07.020","journal-title":"Am Heart J"},{"key":"4021_CR137","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(12)60195-0","volume":"379","author":"RR Makkar","year":"2012","unstructured":"Makkar RR, Smith RR, Cheng K et al (2012) Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial. Lancet 379:895\u2013904. https:\/\/doi.org\/10.1016\/S0140-6736(12)60195-0","journal-title":"Lancet"},{"key":"4021_CR138","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3389\/fgene.2015.00359","volume":"6","author":"A Saric","year":"2016","unstructured":"Saric A, Andreau K, Armand A-S et al (2016) Barth syndrome: From mitochondrial dysfunctions associated with aberrant production of reactive oxygen species to pluripotent stem cell studies. Front Genet 6:359\u2013359. https:\/\/doi.org\/10.3389\/fgene.2015.00359","journal-title":"Front Genet"},{"key":"4021_CR139","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nm.3545","volume":"20","author":"G Wang","year":"2014","unstructured":"Wang G, McCain ML, Yang L et al (2014) Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat Med 20:616\u2013623. https:\/\/doi.org\/10.1038\/nm.3545","journal-title":"Nat Med"},{"key":"4021_CR140","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.109.130054","volume":"53","author":"F Addabbo","year":"2009","unstructured":"Addabbo F, Montagnani M, Goligorsky MS (2009) Mitochondria and reactive oxygen species. Hypertension 53:885\u2013892. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.130054","journal-title":"Hypertension"},{"issue":"2","key":"4021_CR141","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1161\/01.hyp.0000254415.31362.a7","volume":"49","author":"E Takimoto","year":"2007","unstructured":"Takimoto E, Kass DA (2007) Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 49(2):241\u2013248. https:\/\/doi.org\/10.1161\/01.hyp.0000254415.31362.a7","journal-title":"Hypertension"},{"key":"4021_CR142","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.freeradbiomed.2009.05.004","volume":"47","author":"AJ Kowaltowski","year":"2009","unstructured":"Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE (2009) Mitochondria and reactive oxygen species. Free Radical Biol Med 47:333\u2013343. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2009.05.004","journal-title":"Free Radical Biol Med"},{"key":"4021_CR143","doi-asserted-by":"publisher","first-page":"654198","DOI":"10.1155\/2014\/654198","volume":"2014","author":"Q He","year":"2014","unstructured":"He Q, Harris N, Ren J, Han X (2014) Mitochondria-targeted antioxidant prevents cardiac dysfunction induced by tafazzin gene knockdown in cardiac myocytes. Oxid Med Cell Longev 2014:654198\u2013654198. https:\/\/doi.org\/10.1155\/2014\/654198","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"4021_CR144","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1152\/ajpheart.00098.2010","volume":"299","author":"Q He","year":"2010","unstructured":"He Q (2010) Tafazzin knockdown causes hypertrophy of neonatal ventricular myocytes. Am J Physiol Heart Circ Physiol 299(1):210\u2013216. https:\/\/doi.org\/10.1152\/ajpheart.00098.2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4021_CR145","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.jnutbio.2009.11.001","volume":"21","author":"C Liu","year":"2010","unstructured":"Liu C, Cao F, Tang Q-Z et al (2010) Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways. J Nutr Biochem 21:1238\u20131250. https:\/\/doi.org\/10.1016\/j.jnutbio.2009.11.001","journal-title":"J Nutr Biochem"},{"key":"4021_CR146","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1073\/pnas.241655498","volume":"99","author":"M Ott","year":"2002","unstructured":"Ott M, Robertson JD, Gogvadze V et al (2002) Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci USA 99:1259\u20131263. https:\/\/doi.org\/10.1073\/pnas.241655498","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"4021_CR147","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/clpt.2010.22","volume":"87","author":"SP Hersh","year":"2010","unstructured":"Hersh SP (2010) Mitochondria: An emerging target for therapeutics. Clin Pharmacol Ther 87(6):630\u2013632. https:\/\/doi.org\/10.1038\/clpt.2010.22","journal-title":"Clin Pharmacol Ther"},{"key":"4021_CR148","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/clpt.2014.174","volume":"96","author":"HH Szeto","year":"2014","unstructured":"Szeto HH, Birk AV (2014) Serendipity and the discovery of novel compounds that restore mitochondrial plasticity. Clin Pharmacol Ther 96:672\u2013683. https:\/\/doi.org\/10.1038\/clpt.2014.174","journal-title":"Clin Pharmacol Ther"},{"key":"4021_CR149","doi-asserted-by":"publisher","first-page":"34682","DOI":"10.1074\/jbc.M402999200","volume":"279","author":"K Zhao","year":"2004","unstructured":"Zhao K, Zhao G-M, Wu D et al (2004) Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem 279:34682\u201334690. https:\/\/doi.org\/10.1074\/jbc.M402999200","journal-title":"J Biol Chem"},{"key":"4021_CR150","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1111\/bph.12461","volume":"171","author":"HH Szeto","year":"2014","unstructured":"Szeto HH (2014) First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol 171:2029\u20132050. https:\/\/doi.org\/10.1111\/bph.12461","journal-title":"Br J Pharmacol"},{"key":"4021_CR151","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1124\/jpet.102.040147","volume":"304","author":"K Zhao","year":"2003","unstructured":"Zhao K, Luo G, Zhao G-M et al (2003) Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide. J Pharmacol Exp Ther 304:425. https:\/\/doi.org\/10.1124\/jpet.102.040147","journal-title":"J Pharmacol Exp Ther"},{"key":"4021_CR152","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1111\/bph.12468","volume":"171","author":"AV Birk","year":"2014","unstructured":"Birk AV, Chao WM, Bracken C et al (2014) Targeting mitochondrial cardiolipin and the cytochrome c\/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis. Br J Pharmacol 171:2017\u20132028. https:\/\/doi.org\/10.1111\/bph.12468","journal-title":"Br J Pharmacol"},{"key":"4021_CR153","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0014-5793(97)00264-0","volume":"406","author":"G Paradies","year":"1997","unstructured":"Paradies G, Ruggiero FM, Petrosillo G, Quagliariello E (1997) Age-dependent decline in the cytochrome c oxidase activity in rat heart mitochondria: Role of cardiolipin. FEBS Lett 406:136\u2013138. https:\/\/doi.org\/10.1016\/S0014-5793(97)00264-0","journal-title":"FEBS Lett"},{"key":"4021_CR154","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1006\/jmcc.2000.1273","volume":"33","author":"EJ Lesnefsky","year":"2001","unstructured":"Lesnefsky EJ, Gudz TI, Moghaddas S et al (2001) Aging decreases electron transport complex III activity in heart interfibrillar mitochondria by alteration of the cytochrome c binding site. J Mol Cell Cardiol 33:37\u201347. https:\/\/doi.org\/10.1006\/jmcc.2000.1273","journal-title":"J Mol Cell Cardiol"},{"key":"4021_CR155","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neuint.2008.07.001","volume":"53","author":"G Petrosillo","year":"2008","unstructured":"Petrosillo G, Matera M, Casanova G et al (2008) Mitochondrial dysfunction in rat brain with aging: Involvement of complex I, reactive oxygen species and cardiolipin. Neurochem Int 53:126\u2013131. https:\/\/doi.org\/10.1016\/j.neuint.2008.07.001","journal-title":"Neurochem Int"},{"key":"4021_CR156","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/1074248413508003","volume":"19","author":"DA Brown","year":"2014","unstructured":"Brown DA, Hale SL, Baines CP et al (2014) Reduction of early reperfusion injury with the mitochondria-targeting peptide bendavia. J Cardiovasc Pharmacol Ther 19:121\u2013132. https:\/\/doi.org\/10.1177\/1074248413508003","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"4021_CR157","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/cvr\/cvq231","volume":"88","author":"DA Brown","year":"2010","unstructured":"Brown DA, O\u2019Rourke B (2010) Cardiac mitochondria and arrhythmias. Cardiovasc Res 88:241\u2013249. https:\/\/doi.org\/10.1093\/cvr\/cvq231","journal-title":"Cardiovasc Res"},{"key":"4021_CR158","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1056\/NEJMoa071142","volume":"359","author":"C Piot","year":"2008","unstructured":"Piot C, Croisille P, Staat P et al (2008) Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 359:473\u2013481. https:\/\/doi.org\/10.1056\/NEJMoa071142","journal-title":"N Engl J Med"},{"key":"4021_CR159","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1681\/ASN.2012121216","volume":"24","author":"AV Birk","year":"2013","unstructured":"Birk AV, Liu S, Soong Y et al (2013) The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol 24:1250\u20131261. https:\/\/doi.org\/10.1681\/ASN.2012121216","journal-title":"J Am Soc Nephrol"},{"key":"4021_CR160","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jacc.2010.12.044","volume":"58","author":"D-F Dai","year":"2011","unstructured":"Dai D-F, Chen T, Szeto H et al (2011) Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy. J Am Coll Cardiol 58:73\u201382. https:\/\/doi.org\/10.1016\/j.jacc.2010.12.044","journal-title":"J Am Coll Cardiol"},{"key":"4021_CR161","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1161\/CIRCHEARTFAILURE.113.000406","volume":"6","author":"D-F Dai","year":"2013","unstructured":"Dai D-F, Hsieh EJ, Chen T et al (2013) Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides. Circ Heart Fail 6:1067\u20131076. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.113.000406","journal-title":"Circ Heart Fail"},{"key":"4021_CR162","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1097\/CCM.0b013e31821e85ca","volume":"39","author":"S Levine","year":"2011","unstructured":"Levine S, Budak MT, Dierov J, Singhal S (2011) Inactivity-induced diaphragm dysfunction and mitochondria-targeted antioxidants: New concepts in critical care medicine*. Crit Care Med 39:1844\u20131845","journal-title":"Crit Care Med"},{"key":"4021_CR163","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1007\/s11095-011-0476-8","volume":"28","author":"HH Szeto","year":"2011","unstructured":"Szeto HH, Schiller PW (2011) Novel therapies targeting inner mitochondrial membrane\u2013from discovery to clinical development. Pharm Res 28:2669\u20132679. https:\/\/doi.org\/10.1007\/s11095-011-0476-8","journal-title":"Pharm Res"},{"key":"4021_CR164","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.1074\/jbc.RA119.012094","volume":"295","author":"W Mitchell","year":"2020","unstructured":"Mitchell W, Ng EA, Tamucci JD et al (2020) The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action. J Biol Chem 295:7452\u20137469. https:\/\/doi.org\/10.1074\/jbc.RA119.012094","journal-title":"J Biol Chem"},{"key":"4021_CR165","unstructured":"Barth Syndrome Foundation.Summary of stealth BioTherapeutics\u2019s Webinar On clinical trial TAZPOWER.2018. Available from: https:\/\/www.barthsyndrome.org\/research\/clinicaltrials\/tazpower.html. Accessed 16 March 2019"},{"key":"4021_CR166","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/biomedicines6030091","volume":"6","author":"B Salehi","year":"2018","unstructured":"Salehi B, Mishra AP, Nigam M et al (2018) Resveratrol: A double-edged sword in health benefits. Biomedicines 6:91. https:\/\/doi.org\/10.3390\/biomedicines6030091","journal-title":"Biomedicines"},{"key":"4021_CR167","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5935\/0101-2800.20150015","volume":"37","author":"G Albertoni","year":"2015","unstructured":"Albertoni G, Schor N (2015) Resveratrol plays important role in protective mechanisms in renal disease \u2013 mini-review. Brazilian J Nephrol 37:106\u2013114","journal-title":"Brazilian J Nephrol"},{"key":"4021_CR168","doi-asserted-by":"publisher","first-page":"837042","DOI":"10.1155\/2015\/837042","volume":"2015","author":"J Gambini","year":"2015","unstructured":"Gambini J, Ingl\u00e9s M, Olaso G et al (2015) Properties of resveratrol: In vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans. Oxid Med Cell Longev 2015:837042. https:\/\/doi.org\/10.1155\/2015\/837042","journal-title":"Oxid Med Cell Longev"},{"key":"4021_CR169","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/j.bbalip.2016.03.008","volume":"1861","author":"VW Dolinsky","year":"2016","unstructured":"Dolinsky VW, Cole LK, Sparagna GC, Hatch GM (2016) Cardiac mitochondrial energy metabolism in heart failure: Role of cardiolipin and sirtuins. Biochim Biophys Acta Mole Cell Biol Lipids 1861:1544\u20131554. https:\/\/doi.org\/10.1016\/j.bbalip.2016.03.008","journal-title":"Biochim Biophys Acta Mole Cell Biol Lipids"},{"key":"4021_CR170","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/cells7120235","volume":"7","author":"PK Bagul","year":"2018","unstructured":"Bagul PK, Katare PB, Bugga P et al (2018) SIRT-3 modulation by resveratrol improves mitochondrial oxidative phosphorylation in diabetic heart through deacetylation of TFAM. Cells 7:235. https:\/\/doi.org\/10.3390\/cells7120235","journal-title":"Cells"},{"key":"4021_CR171","doi-asserted-by":"publisher","first-page":"6452","DOI":"10.1074\/jbc.R116.771915","volume":"292","author":"H Pan","year":"2017","unstructured":"Pan H, Finkel T (2017) Key proteins and pathways that regulate lifespan. J Biol Chem 292:6452\u20136460. https:\/\/doi.org\/10.1074\/jbc.R116.771915","journal-title":"J Biol Chem"},{"key":"4021_CR172","doi-asserted-by":"publisher","first-page":"109767","DOI":"10.1016\/j.biopha.2019.109767","volume":"125","author":"D-D Huang","year":"2020","unstructured":"Huang D-D, Shi G, Jiang Y et al (2020) A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications. Biomed Pharmacother 125:109767. https:\/\/doi.org\/10.1016\/j.biopha.2019.109767","journal-title":"Biomed Pharmacother"},{"key":"4021_CR173","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.atherosclerosis.2011.11.006","volume":"220","author":"T Yashiro","year":"2012","unstructured":"Yashiro T, Nanmoku M et al (2012) Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins. Atherosclerosis 220:369\u2013374","journal-title":"Atherosclerosis"},{"key":"4021_CR174","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ (2018) AMPK: Guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol 19:121\u2013135. https:\/\/doi.org\/10.1038\/nrm.2017.95","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4021_CR175","doi-asserted-by":"publisher","first-page":"15983","DOI":"10.1073\/pnas.252625599","volume":"99","author":"H Zong","year":"2002","unstructured":"Zong H, Ren JM, Young LH et al (2002) AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci USA 99:15983\u201315987. https:\/\/doi.org\/10.1073\/pnas.252625599","journal-title":"Proc Natl Acad Sci USA"},{"key":"4021_CR176","doi-asserted-by":"publisher","first-page":"8375","DOI":"10.1074\/jbc.M109.090266","volume":"285","author":"M Tanno","year":"2010","unstructured":"Tanno M, Kuno A, Yano T et al (2010) Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem 285:8375\u20138382. https:\/\/doi.org\/10.1074\/jbc.M109.090266","journal-title":"J Biol Chem"},{"key":"4021_CR177","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bbalip.2009.09.011","volume":"1801","author":"P Schrauwen","year":"2010","unstructured":"Schrauwen P, Schrauwen-Hinderling V, Hoeks J, Hesselink MKC (2010) Mitochondrial dysfunction and lipotoxicity. Biochim Biophys Acta Mol Cell Biol Lipids 1801:266\u2013271. https:\/\/doi.org\/10.1016\/j.bbalip.2009.09.011","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"4021_CR178","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.bbalip.2009.09.023","volume":"1801","author":"AR Wende","year":"2010","unstructured":"Wende AR, Abel ED (2010) Lipotoxicity in the heart. Biochim Biophys Acta 1801:311\u2013319. https:\/\/doi.org\/10.1016\/j.bbalip.2009.09.023","journal-title":"Biochim Biophys Acta"},{"key":"4021_CR179","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yjmcc.2020.05.001","volume":"144","author":"LK Cole","year":"2020","unstructured":"Cole LK, Mejia EM, Sparagna GC et al (2020) Cardiolipin deficiency elevates susceptibility to a lipotoxic hypertrophic cardiomyopathy. J Mol Cell Cardiol 144:24\u201334. https:\/\/doi.org\/10.1016\/j.yjmcc.2020.05.001","journal-title":"J Mol Cell Cardiol"},{"key":"4021_CR180","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.plipres.2005.12.001","volume":"45","author":"KD Hauff","year":"2006","unstructured":"Hauff KD, Hatch GM (2006) Cardiolipin metabolism and Barth syndrome. Prog Lipid Res 45:91\u2013101. https:\/\/doi.org\/10.1016\/j.plipres.2005.12.001","journal-title":"Prog Lipid Res"},{"key":"4021_CR181","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.3390\/ijms19072026","volume":"19","author":"P Agarwal","year":"2018","unstructured":"Agarwal P, Cole LK, Chandrakumar A et al (2018) Phosphokinome analysis of Barth syndrome lymphoblasts identify novel targets in the pathophysiology of the disease. Int J Mol Sci 19:2026. https:\/\/doi.org\/10.3390\/ijms19072026","journal-title":"Int J Mol Sci"},{"key":"4021_CR182","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.chemphyslip.2013.12.009","volume":"179","author":"V Raja","year":"2014","unstructured":"Raja V, Greenberg ML (2014) The functions of cardiolipin in cellular metabolism-potential modifiers of the Barth syndrome phenotype. Chem Phys Lipid 179:49\u201356. https:\/\/doi.org\/10.1016\/j.chemphyslip.2013.12.009","journal-title":"Chem Phys Lipid"},{"key":"4021_CR183","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.chemphyslip.2015.09.005","volume":"193","author":"GJ Gaspard","year":"2015","unstructured":"Gaspard GJ, McMaster CR (2015) Cardiolipin metabolism and its causal role in the etiology of the inherited cardiomyopathy Barth syndrome. Chem Phys Lipid 193:1\u201310. https:\/\/doi.org\/10.1016\/j.chemphyslip.2015.09.005","journal-title":"Chem Phys Lipid"},{"key":"4021_CR184","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11745-016-4229-7","volume":"52","author":"N Ikon","year":"2017","unstructured":"Ikon N, Ryan RO (2017) Barth syndrome: Connecting cardiolipin to cardiomyopathy. Lipids 52:99\u2013108. https:\/\/doi.org\/10.1007\/s11745-016-4229-7","journal-title":"Lipids"},{"key":"4021_CR185","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10545-016-9933-1","volume":"39","author":"N Ikon","year":"2016","unstructured":"Ikon N, Ryan RO (2016) On the origin of 3-methylglutaconic acid in disorders of mitochondrial energy metabolism. J Inherit Metab Dis 39:749\u2013756. https:\/\/doi.org\/10.1007\/s10545-016-9933-1","journal-title":"J Inherit Metab Dis"},{"key":"4021_CR186","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/s0022-3476(05)82199-7","volume":"118","author":"KM Gibson","year":"1991","unstructured":"Gibson KM, Sherwood WG, Hoffman GF, Stumpf DA, Dianzani I, Schutgens RB, Barth PG, Weismann U, Bachmann C, Schrynemackers-Pitance P, Verloes A, Narisawa K, Mino M, Ohya A, Kelley RI (1991) Phenotypic heterogeneity in the syndromes of 3-methylglutaconic aciduria. J Pediatr 118:885\u201390. https:\/\/doi.org\/10.1016\/s0022-3476(05)82199-7","journal-title":"J Pediatr"},{"key":"4021_CR187","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10545-012-9453-6","volume":"35","author":"JB Roullet","year":"2012","unstructured":"Roullet JB, Merkens LS, Pappu AS, Jacobs MD, Winter R, Connor WE, Steiner RD (2012) No evidence for mevalonate shunting in moderately affected children with Smith-Lemli-Opitz syndrome. J Inherit Metab Dis 35:859\u2013869. https:\/\/doi.org\/10.1007\/s10545-012-9453-6","journal-title":"J Inherit Metab Dis"},{"key":"4021_CR188","doi-asserted-by":"publisher","first-page":"e59267","DOI":"10.1371\/journal.pone.0059267","volume":"8","author":"YH Hsu","year":"2013","unstructured":"Hsu YH, Dumlao DS, Cao J, Dennis EA (2013) Assessing phospholipase A2 activity toward cardiolipin by mass spectrometry. PloS ONE 8:e59267. https:\/\/doi.org\/10.1371\/journal.pone.0059267","journal-title":"PloS ONE"},{"key":"4021_CR189","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.13973","author":"RLS Goncalves","year":"2020","unstructured":"Goncalves RLS, Schlame M, Bartelt A, Brand MD, Hotam\u0131\u015fl\u0131gil GS (2020) Cardiolipin deficiency in Barth syndrome is not associated with increased superoxide\/H 2 O 2 production in heart and skeletal muscle mitochondria. FEBS Lett. https:\/\/doi.org\/10.1002\/1873-3468.13973","journal-title":"FEBS Lett"},{"key":"4021_CR190","doi-asserted-by":"publisher","first-page":"12485","DOI":"10.1074\/jbc.RA119.011229","volume":"295","author":"CH Le","year":"2020","unstructured":"Le CH, Benage LG, Specht KS, Li Puma LC, Mulligan CM, Heuberger AL, Prenni JE, Claypool SM, Chatfield KC, Sparagna GC, Chicco AJ (2020) Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria. J Biol Chem 295:12485\u201312497. https:\/\/doi.org\/10.1074\/jbc.RA119.011229","journal-title":"J Biol Chem"},{"key":"4021_CR191","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.3390\/cells9102333","volume":"9","author":"PX Petit","year":"2020","unstructured":"Petit PX, Ardilla-Osorio H, Penalvia L, Rainey NE (2020) Tafazzin mutation affecting cardiolipin leads to increased mitochondrial superoxide anions and mitophagy inhibition in Barth syndrome. Cells 9:2333. https:\/\/doi.org\/10.3390\/cells9102333","journal-title":"Cells"},{"key":"4021_CR192","doi-asserted-by":"publisher","first-page":"11928","DOI":"10.1074\/jbc.RA120.013960","volume":"295","author":"Y Li","year":"2020","unstructured":"Li Y, Lou W, Grevel A, B\u00f6ttinger L, Liang Z, Ji J, Patil VA, Liu J, Ye C, H\u00fcttemann M, Becker T, Greenberg ML (2020) Cardiolipin-deficient cells have decreased levels of the iron-sulfur biogenesis protein frataxin. J Biol Chem 295:11928\u201311937. https:\/\/doi.org\/10.1074\/jbc.RA120.013960","journal-title":"J Biol Chem"},{"key":"4021_CR193","doi-asserted-by":"publisher","first-page":"16383","DOI":"10.1073\/pnas.2000640117","volume":"117","author":"S Ghosh","year":"2020","unstructured":"Ghosh S, Basu Ball W, Madaris TR, Srikantan S, Madesh M, Mootha VK, Gohil VM (2020) An essential role for cardiolipin in the stability and function of the mitochondrial calcium uniporter. Proc Natl Acad Sci 117:16383\u201316390. https:\/\/doi.org\/10.1073\/pnas.2000640117","journal-title":"Proc Natl Acad Sci"},{"key":"4021_CR194","doi-asserted-by":"publisher","first-page":"158677","DOI":"10.1016\/j.bbalip.2020.158677","volume":"1865","author":"JC Bozelli Jr","year":"2020","unstructured":"Bozelli JC Jr, Lu D, Atilla-Gokcumen GE, Epand RM (2020) Promotion of plasmalogen biosynthesis reverse lipid changes in a Barth Syndrome cell model. Biochim Biophys Acta Mol Cell Biol Lipids 1865:158677. https:\/\/doi.org\/10.1016\/j.bbalip.2020.158677","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-020-04021-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-020-04021-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-020-04021-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T13:17:26Z","timestamp":1614604646000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-020-04021-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":194,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["4021"],"URL":"https:\/\/doi.org\/10.1007\/s11010-020-04021-0","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"21 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}